anonymous
Guest
anonymous
Guest
Looking for honest feedback please. I am currently in rheumatology for another organization but have been contacted by a recruiter for a position at Amgen promoting Otezla. I asked my providers about it and they told me that Otezla has been a great medication but resources have really gone down hill since Amgen bought Otezla from Celgene. I have asked half a dozen providers now and they all say they don’t let their Otezla reps in anymore. What will that mean for this role? Are the territories massive now? Is it a mostly virtual role? To be honest it sounds like maybe I won’t have to work much, which is honestly an ideal situation.